• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Duration of Initial Empirical Antibiotic Therapy and Outcomes in Very Low Birth Weight Infants

byStudy Graphics | C.WuandConstance Wu
September 6, 2020
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Very low birth weight (VLBW) infants who received antibiotics for 4 to 7 days had significant increased odds of short term morbidity and mortality.

2. Each day of antibiotic use among VLBW infants was associated with about 5% greater odds of major adverse outcomes.

Evidence Rating: 2 (Good)

Study Rundown: Early onset sepsis (EOS) is a serious problem among VLBW neonates, therefore providers often initiate empiric antibiotics. These medications are usually discontinue if blood cultures remain negative at 48 hours. However, antibiotic use, especially if prolonged, is also associated with increased rates of morbidity and mortality. In this study, investigators retrospectively reviewed data from patients admitted to Canadian Neonatal Intensive Care Units (NICUs) to analyze the effect of antibiotic duration on short-term morbidity and mortality in VLBW infants. Participants without culture-proven sepsis were divided into 3 groups based on days of antibiotic exposure (0 days, 1 to 3 days, 4 to 7 days) within the first week of life. Results showed infants who had the longest length of antibiotic use (4 to 7 days) had significantly higher odds of major adverse outcomes compared to those with no antibiotic exposure. Furthermore, each additional day of antibiotic use was associated with about 5% higher odds of major morbidity among VLBW infants. Similar results were seen among subgroup analyses of both extremely low birth weight (ELBW) infants, and among VLBW infants who were at very low risk of early onset sepsis (EOS). This study does not account for differences in effects of specific individual antibiotics, nor can it fully account for confounders such as illness severity. Nevertheless, results suggest providers should be cautious when using empiric antibiotics among VLBW neonates.

Click to read the study in Pediatrics

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Risk of bloodstream infections with indwelling peripheral catheters increase after 3 days

#VisualAbstract Seven Days of Antibiotic Treatment Non-inferior to 14 Days for Bloodstream Infections

The 2 Minute Medicine Podcast Episode 54

Tags: antibioticsneonatology
Previous Post

#VisualAbstract: Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

Next Post

The PreVent trial: bag-mask ventilation decreases hypoxia in patients undergoing tracheal intubation

RelatedReports

Quick Take: Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG)
Hematology

Risk of bloodstream infections with indwelling peripheral catheters increase after 3 days

April 28, 2025
#VisualAbstract Seven Days of Antibiotic Treatment Non-inferior to 14 Days for Bloodstream Infections
StudyGraphics

#VisualAbstract Seven Days of Antibiotic Treatment Non-inferior to 14 Days for Bloodstream Infections

March 26, 2025
The 2 Minute Medicine Podcast Episode 15
2MM Podcast

The 2 Minute Medicine Podcast Episode 54

March 21, 2025
Oral amoxicillin as effective as injectable benzylpenicillin-gentamicin for infants with infection in which referral not possible [AFRINEST Trial]
Infectious Disease

Seven days of antibiotic treatment non-inferior to 14 days for bloodstream infections

March 18, 2025
Next Post
Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure

The PreVent trial: bag-mask ventilation decreases hypoxia in patients undergoing tracheal intubation

Increasing C-section room temperature linked to reduced neonatal, maternal hypothermia

Maternal gratitude linked to improved medical staff functioning

The SOLO1 trial: Olaparib significantly delays progression of advanced ovarian cancer

The LION trial: systemic lymphadenectomy in advanced ovarian cancer patients provides no survival benefits

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
  • Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
  • Mazdutide significantly reduces weight in adults with overweight or obesity
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.